Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-11.93 Insider Own2.70% Shs Outstand1.08B Perf Week3.35%
Market Cap20.96B Forward P/E6.90 EPS next Y2.82 Insider Trans-0.05% Shs Float1.05B Perf Month22.47%
Income-12120.00M PEG- EPS next Q0.54 Inst Own59.80% Short Float3.50% Perf Quarter-9.19%
Sales19.75B P/S1.06 EPS this Y-26.90% Inst Trans0.01% Short Ratio3.18 Perf Half Y-16.05%
Book/sh13.66 P/B1.42 EPS next Y-3.82% ROA-16.30% Target Price22.71 Perf Year-7.42%
Cash/sh1.74 P/C11.18 EPS next 5Y-7.33% ROE-78.00% 52W Range14.59 - 25.96 Perf YTD26.20%
Dividend- P/FCF8.54 EPS past 5Y-57.50% ROI-36.00% 52W High-25.04% Beta1.35
Dividend %- Quick Ratio0.60 Sales past 5Y2.00% Gross Margin45.40% 52W Low33.38% ATR0.68
Employees51800 Current Ratio0.90 Sales Q/Q-19.40% Oper. Margin-59.00% RSI (14)62.89 Volatility2.42% 3.77%
OptionableYes Debt/Eq2.12 EPS Q/Q-151.50% Profit Margin-56.00% Rel Volume1.02 Prev Close18.75
ShortableYes LT Debt/Eq1.93 EarningsFeb 13 BMO Payout- Avg Volume11.56M Price19.46
Recom2.80 SMA2013.08% SMA500.44% SMA200-8.27% Volume11,722,934 Change3.79%
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-17-18Upgrade BTIG Research Sell → Neutral
Sep-07-18Downgrade Credit Suisse Outperform → Neutral
Jun-27-18Reiterated Citigroup Buy $25 → $27
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
Jan-26-18Reiterated Leerink Partners Underperform $15 → $17
Jan-25-18Reiterated Susquehanna Positive $22 → $24
Jan-18-18Downgrade BTIG Research Buy → Neutral
Jan-09-18Upgrade Mizuho Neutral → Buy $23
Jan-05-18Downgrade Wells Fargo Market Perform → Underperform
Jan-23-19 11:00AM  Teva Has Potential For 6% CAGR Ahead, UBS Says In Upgrade Benzinga
Jan-22-19 10:27AM  U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva Reuters
10:10AM  U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva Reuters
Jan-21-19 01:20PM  Merck's Partner Gets FDA Nod for Herceptin Biosimilar Zacks
Jan-17-19 05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know Zacks
Jan-16-19 09:25AM  6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019 Zacks
Jan-14-19 06:00PM  Is Teva Pharmaceutical Industries Limited Stock a Bargain? Motley Fool
04:22PM  Will Biogen Jump On This Biotech Stock Amid Buying Spree? Investor's Business Daily
04:00PM  Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results at 8 a.m. ET on February 13, 2019 Business Wire
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
Jan-11-19 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
Jan-10-19 11:00AM  INSYS Therapeutics Rises on Dose-Ranging Allergy Study Data Zacks
09:31AM  The Zacks Analyst Blog Highlights: Berkshire Hathaway, Teva Pharmaceutical Industries, Visa, American Express, Liberty Latin America and Sirius XM Zacks
Jan-09-19 08:23AM  5 Must-Watch Warren Buffett Stocks for 2019 Zacks
Jan-07-19 06:18PM  Regeneron, Sanofi Restructure Immuno-Oncology Collaboration Zacks
07:21AM  The 3 Best Warren Buffett Stocks to Buy in 2019 Motley Fool
Jan-06-19 12:45PM  Teva to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-03-19 03:29PM  VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster Zacks
03:03PM  Teva (TEVA) Ends Dispute with Amgen Over Generic Sensipar Zacks
07:45AM  Stocks making the biggest moves premarket: AAPL, CELG, JNJ, UBS & more CNBC
07:36AM  The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen Benzinga
03:30AM  Stocks - Apple Plunges in Premarket; Celgene, IZEA Soar; Starbucks, Amgen Drop
Jan-02-19 09:33PM  Teva, Amgen end dispute over generic Cinacalcet HCl tablets Reuters
08:28PM  Teva and Amgen Resolve Ongoing Dispute Over Tevas Generic Cinacalet HCl Product Business Wire
03:48PM  Cannabis, Migraines, Gene-Silencing: FDA Approvals Hit High Note In 2018 Investor's Business Daily
Dec-31-18 04:15PM  Does Pfizer Have A Multibillion-Dollar Replacement For Opioids? Investor's Business Daily
Dec-29-18 05:06AM  These Are the Stocks Warren Buffett Bought and Sold in 2018 GOBankingRates
Dec-28-18 09:55AM  Generic Industry on Path to Recovery: 3 Hot Picks for 2019 Zacks
08:21AM  My Top Portfolio Holdings for 2019 Motley Fool
Dec-27-18 12:05PM  Teva Announces US Launch of a Generic Version of Elidel® (Pimecrolimus) Cream, 1% Business Wire
09:39AM  Teva Stock Rises on Patent Settlement With Neos Therapeutics Zacks
09:37AM  Company News For Dec 27, 2018 Zacks
07:06AM  Teva shares surge 5% on news of patent settlement with Neos over ADHD drug MarketWatch
Dec-26-18 03:50PM  US Stocks Rally on Wednesday +8.43%
03:12PM  Value Investors Should Buy into the Teva Stock Dip InvestorPlace
10:48AM  Neos, Teva settle litigation over ADHD drug American City Business Journals
10:29AM  Roku soars, Teva reaches settlement, AMC gets a boost Yahoo Finance Video
08:00AM  Teva shares up 2.5% premarket after reaching patent settlement with Neos MarketWatch
06:36AM  3 of the Cheapest Drug Stocks You Can Buy in 2019 Motley Fool
Dec-22-18 11:06AM  ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors ProAir® Digihaler (albuterol sulfate 117 mcg) Inhalation Powder Business Wire
Dec-21-18 03:19PM  Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors ProAir® Digihaler (albuterol sulfate 117 mcg) Inhalation Powder Business Wire
Dec-20-18 03:50PM  Lilly's Shares Rise on Robust 2019 View, Dividend Hike Zacks
11:20AM  I See No Technical Reason to Approach Teva Pharmaceuticals From the Long Side
10:18AM  Allergan Drops, Stops Textured Breast Implant Sales in Europe Zacks
09:10AM  Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? Zacks
07:05AM  Today's Research Reports on Trending Tickers: Allergan and Teva Pharmaceutical ACCESSWIRE
Dec-19-18 08:12PM  Fighting the Fed: Cramer's 'Mad Money' Recap (Wednesday 12/19/18)
07:07PM  Cramer's lightning round: Sell Tevadebt is not king in t... CNBC Videos
06:49PM  Cramer's lightning round: Sell Tevadebt is not king in this environment CNBC
06:47PM  Eli Lilly CEO on winning in migraine treatments: 'It's a horse race between three great companies' CNBC
Dec-18-18 09:50AM  Teva Reports Positive Top-Line Data for Migraine Candidate Zacks
09:47AM  Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug Zacks
06:06AM  3 Value Stocks to Absolutely Love During This Correction Motley Fool
Dec-17-18 08:00AM  Teva Announces Positive Topline Phase IIIb Results with Fremanezumab in Adults with Migraine Who Did Not Respond to Multiple Classes of Preventive Treatments Business Wire
Dec-14-18 06:31PM  Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications Business Wire
Dec-13-18 11:14AM  Should Warren Buffett And You Buy More TEVA Stock Right Now? InvestorPlace
10:54AM  Teva Pharm to move headquarters to Tel Aviv Reuters
Dec-11-18 03:50PM  Warren Buffett's 10 Big Stock Losers Investopedia
03:03PM  Teva (TEVA) Stock Poised to Record Big Gains in 2019? Zacks
09:23AM  Generic Drugmakers Down on Allegations of Price Fixing Zacks
07:44AM  3 Big Stock Charts for Tuesday: Micron Technology, Fortive and Morgan Stanley InvestorPlace
06:57AM  Generic-drug stocks slammed by report of expanded price-fixing probe MarketWatch
06:55AM  Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Innovate Biopharmaceuticals ACCESSWIRE
Dec-10-18 04:35PM  Why Teva Pharmaceutical Industries, Tivity Health, and Marine Products Slumped Today Motley Fool
11:30AM  Generic drug makers stocks fall sharply after report of expanded price-fixing probe MarketWatch
09:45AM  ATRS: Xyosted & Epi Pen Available for Sale Zacks Small Cap Research
Dec-09-18 01:24PM  Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy? Insider Monkey
Dec-06-18 02:49PM  Roche's Kadcyla Halves Death Risk in Breast Cancer Study Zacks
Dec-05-18 09:14AM  Mylan Expands Recall of Valsartan to All Unexpired Lots Zacks
Dec-04-18 02:39PM  Roche Announces Positive Data on Venclexta/Venclyxto at ASH Zacks
02:28PM  U.S. justices wrestle with patent arguments for anti-nausea drug Reuters
Dec-03-18 09:00AM  AbbVie Presents Long-Term Data on Cancer Drugs at ASH 2018 Zacks
Nov-30-18 03:19PM  Novartis' Gilenya Approved in EU for Expanded Population Zacks
Nov-29-18 05:28PM  A Pharmaceutical Company With a Resilient Portfolio and Solid Pipeline
10:11AM  Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma Zacks
08:50AM  Detailed Research: Economic Perspectives on American Tower Corporation (REIT), Ligand Pharmaceuticals, Teva Pharmaceutical Industries, Cummins, Alexander's, and Korea Electric Power What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-28-18 05:19PM  Galapagos' Osteoarthritis Candidate Gets Fast Track Status Zacks
03:38PM  Celltrion and Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkins Lymphoma Indications Business Wire
08:39AM  Teva (TEVA) Launches First Generic Version of Mylan's EpiPen Zacks
07:50AM  Stocks making the biggest move premarket: DKS, TIF, SJM, CRM, HUM, BKS & more CNBC
Nov-27-18 05:02PM  Teva to recall certain blood pressure medicine in U.S. Reuters
01:48PM  Teva prices EpiPen generic at $300, same price as Mylan generic Reuters
01:47PM  Teva's generic EpiPen hits the market in limited doses American City Business Journals
01:10PM  Teva prices EpiPen generic at $300, same price as Mylan generic Reuters
11:38AM  [$$] Teva Releases Generic EpiPen in Limited Doses in the U.S. The Wall Street Journal
10:39AM  Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease Zacks
10:35AM  Teva prices EpiPen generic at $300 Reuters
10:06AM  Tevas Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in the United States Business Wire
Nov-26-18 09:43AM  4 Reasons Why Lilly is Up More Than 30% This Year So Far Zacks
Nov-25-18 09:35AM  9 Policy Catalysts For Health Care Investors To Watch Before Year's End Benzinga
Nov-22-18 08:31AM  J&J Loses Appeal to Halt Generic Zytiga Launch, Stock Down Zacks
Nov-21-18 07:05AM  Today's Research Reports on Trending Tickers: Mylan and Teva Pharmaceutical Industries ACCESSWIRE
Nov-19-18 08:57AM  J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment Zacks
Nov-16-18 04:16PM  Regeneron (REGN) Rides on Eylea and Dupixent's Performance Zacks
09:15AM  Why Teva Pharmaceutical Is Up 20% in 2018 So Far Motley Fool
Nov-14-18 04:06PM  Migraine-Focused Biotech Has A Headache On Quarterly Losses Investor's Business Daily
07:46AM  Jim Cramer Weighs In On Dropbox, Teva And More Benzinga
Nov-13-18 06:46PM  Cramer's lightning round: Dropbox's stock is a buy even after the tech sell-off CNBC
Nov-12-18 09:29PM  4 Stocks Warren Buffett and Insiders Are Piling On Insider Monkey
Nov-08-18 08:32AM  Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow InvestorPlace
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM
Fridriksdottir HafrunExecutive VP, Global R&DNov 30Sale21.7693320,3048,829Dec 04 08:09 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM
Daniell RichardExec. VP, European CommercialSep 10Sale21.2569614,7900Sep 11 04:17 PM
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM
MIGNONE ROBERTODirectorMay 10Buy19.32250,0004,829,7001,500,000May 11 04:15 PM
MIGNONE ROBERTODirectorMay 09Buy19.21500,0009,603,1501,250,000May 11 04:15 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 19Sale18.382,35843,3402,974Mar 20 04:16 PM
O'Grady Brendan P.EVP, North America CommercialMar 19Sale17.881,17921,0781,388Mar 20 04:13 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 19Sale17.894578,1775,746Mar 20 04:11 PM
McClellan Michael JamesEVP, Chief Financial OfficerMar 19Sale17.882875,13111,295Mar 20 04:10 PM
Griffin Deborah AChief Accounting OfficerMar 19Sale17.8894316,8590Mar 20 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 19Sale17.883486,2227,051Mar 20 04:07 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 19Sale17.8857110,2084,445Mar 20 04:06 PM
Daniell RichardExec. VP, European CommercialMar 19Sale17.891,29723,2060Mar 20 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale19.202,44146,8672,974Mar 14 04:35 PM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale19.4973814,3831,388Mar 14 04:34 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale19.504618,9895,331Mar 14 04:31 PM
Griffin Deborah AChief Accounting OfficerMar 12Sale19.4995218,5540Mar 14 04:29 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale19.4957611,2263,837Mar 14 04:26 PM
Daniell RichardExec. VP, European CommercialMar 12Sale19.5071413,9220Mar 14 04:23 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale19.3870513,6631,388Mar 06 04:20 PM
Griffin Deborah AChief Accounting OfficerMar 05Sale19.3877314,9810Mar 06 04:14 PM
Daniell RichardExec. VP, European CommercialMar 05Sale19.281,10821,3620Mar 06 04:08 PM
Sabag MarkEVP, Global Human ResourcesFeb 15Sale20.523,00061,56041,517Feb 20 08:31 AM
Sabag MarkEVP, Global Human ResourcesFeb 14Sale18.452,05037,82344,517Feb 20 08:31 AM